Please provide your email address to receive an email when new articles are posted on . OSSIO announced FDA clearance of its OSSIOfiber bio-integrative bone fixation technology for use in pediatric ...
Please provide your email address to receive an email when new articles are posted on . The FDA has announced a final order to classify the screw sleeve bone fixation device into class II with special ...
The US Food and Drug Administration (FDA) recently finalized an order classifying in vivo cured intramedullary fixation rods as class II devices. The final order—effective as of 8 June—is aimed at ...
Broader indications reinforce SINEFIX as a versatile alternative to traditional suture anchors for soft tissue-to-bone fixation. MINNEAPOLIS, April 21, 2026 /PRNewswire/ -- Inovedis Inc., a ...
SANTA CLARA, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, ...
SANTA CLARA, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, ...
Evonik, a specialist for advanced biomaterials and application technology solutions for bioresorbable implants, announced the launch of its first product grade from a new line of Resomer Composite ...
Inovedis Inc., a cutting-edge orthopedic company, announced today that the U.S. Food and Drug Administration (FDA) has cleared expanded clinical applications for the SINEFIX Implant. Designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results